Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
1.197
+0.057 (5.01%)
At close: Mar 9, 2026, 4:00 PM EDT
1.200
+0.003 (0.24%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Lite Strategy Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
43.53M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 31.80M |
| Veru Inc. | 16.89M |
| Palatin Technologies | 8.96M |
| Apollomics | 6.93M |
| Aligos Therapeutics | 2.19M |
LITS News
- 20 days ago - Lite Strategy Reports Fiscal 2026 Second Quarter Results - GlobeNewsWire
- 6 months ago - MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS' - Business Wire
- 7 months ago - MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
- 8 months ago - BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode - TheNewswire
- 8 months ago - MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 8 months ago - Why Is MEI Pharma Stock Soaring On Friday? - Benzinga
- 8 months ago - MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 10 months ago - MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - Business Wire